Uduak Thomas

For modern biotherapeutics, cell line development workflows must include more than just automated liquid handling.

Study links endogenous retroviruses to epithelial cancers, suggests editing them could make cancer therapies more effective.

The technology generates RNA comparable to current industry standards, without the toxic byproducts associated with chemical synthesis.

Scientists have developed a cancer kill switch that triggers apoptosis when it is exposed to acidic tumor microenvironment.

The software, called SQUID, uses deep neural networks to help interpret how AI models interpret genomic data.

Scientists found that FUS protein aggregates in FTLD and ALS act like seeds causing more clusters to form and spread throughout the brain.

The engineered cell’s ability to reorganize itself in response to environmental signals mimics biological cells’ response to chemical stimuli.

The improved gene-editing approach combines prime editors with a more efficient recombinase to insert or substitute gene-sized DNA segments.

Low success rates can be intimidating in drug development, but they may become less of an issue now that AI is starting to home in on the most promising candidates.

The company plans to develop novel drugs that use RNA sensors to turn on therapeutic protein translation in target cells.